| Views | |
|---|---|
| CD206-Targeted Liposomal Myelin Basic Protein Peptides in Patients with Multiple Sclerosis Resistant to First-Line Disease-Modifying Therapies: A First-in-Human, Proof-of-Concept Dose-Escalation Study | 250 |
| January 2026 | February 2026 | March 2026 | April 2026 | May 2026 | June 2026 | July 2026 | |
|---|---|---|---|---|---|---|---|
| CD206-Targeted Liposomal Myelin Basic Protein Peptides in Patients with Multiple Sclerosis Resistant to First-Line Disease-Modifying Therapies: A First-in-Human, Proof-of-Concept Dose-Escalation Study | 3 | 2 | 10 | 9 | 2 | 11 | 4 |
| Views | |
|---|---|
| SCOPUS19337213-2016-13-4-SID84975221908-a1.pdf | 40 |
| Views | |
|---|---|
| Russia | 83 |
| Views | |
|---|---|
| Kazan | 83 |